• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

女性行剖宫产术治疗胎盘植入谱系疾病的泌尿系统并发症:系统评价和荟萃分析。

Urological complications in women undergoing Cesarean section for placenta accreta spectrum disorders: systematic review and meta-analysis.

机构信息

Center for Fetal Care and High-Risk Pregnancy, Department of Obstetrics and Gynecology, University of Chieti, Chieti, Italy.

EGA Institute for Women's Health, Faculty of Population Health Sciences, University College London, London, UK.

出版信息

Ultrasound Obstet Gynecol. 2023 Nov;62(5):633-643. doi: 10.1002/uog.26299.

DOI:10.1002/uog.26299
PMID:37401769
Abstract

OBJECTIVE

To report on the occurrence of urological complications in women undergoing Cesarean section for placenta accreta spectrum disorders (PAS).

METHODS

MEDLINE, EMBASE and the Cochrane databases were searched electronically up to 1 November 2022. Studies reporting on the urological outcome of women undergoing Cesarean section for PAS were included. Two independent reviewers performed data extraction using a predefined protocol and assessed the risk of bias using the Newcastle-Ottawa scale for observational studies, with disagreements resolved by consensus.The primary outcome was the overall occurrence of urological complications. Secondary outcomes were the occurrence of any cystotomy, intentional cystotomy, unintentional cystotomy, ureteral damage, ureteral fistula and vesicovaginal fistula. All outcomes were explored in the overall population of women undergoing surgery for PAS. In addition, we performed subgroup analyses according to the type of surgery (Cesarean hysterectomy, or conservative surgery or management), severity of PAS at histopathology (placenta accreta/increta and placenta percreta), type of intervention (planned vs emergency) and number of cases per year. Random-effects meta-analyses of proportions were used to analyze the data.

RESULTS

There were 62 studies included in the systematic review and 56 were included in the meta-analysis. Urological complications occurred in 15.2% (95% CI, 12.9-17.7%) of cases. Cystotomy complicated 13.5% (95% CI, 9.7-17.9%) of surgical operations. Intentional cystotomy was required in 7.7% (95% CI, 6.5-9.1%) of cases, while unintentional cystotomy occurred in 7.2% (95% CI, 6.0-8.5%) of cases. Urological complications occurred in 19.4% (95% CI, 16.3-22.7%) of cases undergoing hysterectomy and 12.2% (95% CI, 7.5-17.8%) of those undergoing conservative treatment. In the subgroup analyses, urological complications occurred in 9.4% (95% CI, 5.4-14.4%) of women with placenta accreta/increta and 38.5% (95% CI, 21.6-57.0%) of those described as having placenta percreta, and included mainly cystotomy (5.5% (95% CI, 0.6-15.1%) and 22.0% (95% CI, 5.4-45.5%), respectively). Urological complications occurred in 15.4% (95% CI, 8.1-24.6%) of cases undergoing a planned procedure and 24.6% (95% CI, 13.0-38.5%) of those undergoing an emergency intervention. In subanalysis of studies reporting on ≥ 12 cases per year, the incidence of urological complication was similar to that reported in the primary analysis.

CONCLUSIONS

Women undergoing surgery for PAS are at high risk of urological complication, mainly cystotomy. The incidence of these complications was particularly high in women described as having placenta percreta at birth and in those undergoing emergency surgical intervention. The high heterogeneity between the included studies highlights the need for a standardized protocol for the diagnosis of PAS to identify prenatal imaging signs associated with the increased risk of urological morbidity at delivery. © 2023 International Society of Ultrasound in Obstetrics and Gynecology.

摘要

目的

报告胎盘植入谱系疾病(PAS)行剖宫产术的女性发生泌尿系统并发症的情况。

方法

电子检索 MEDLINE、EMBASE 和 Cochrane 数据库,截至 2022 年 11 月 1 日。纳入报告 PAS 行剖宫产术女性泌尿系统结局的研究。两名独立审查员使用预定义方案提取数据,并使用纽卡斯尔-渥太华量表评估观察性研究的偏倚风险,存在分歧时通过共识解决。主要结局为泌尿系统并发症的总体发生率。次要结局为任何膀胱切开术、有意膀胱切开术、无意膀胱切开术、输尿管损伤、输尿管瘘和膀胱阴道瘘的发生率。所有结局均在 PAS 手术的女性总体人群中进行探讨。此外,我们根据手术类型(剖宫产子宫切除术、保守性手术或管理)、组织学 PAS 严重程度(胎盘植入/胎盘粘连和胎盘穿透性)、干预类型(计划性 vs 紧急性)和每年病例数进行了亚组分析。使用随机效应荟萃分析比例来分析数据。

结果

系统评价纳入 62 项研究,56 项研究纳入荟萃分析。泌尿系统并发症发生率为 15.2%(95%CI,12.9%-17.7%)。膀胱切开术使 13.5%(95%CI,9.7%-17.9%)的手术复杂化。7.7%(95%CI,6.5%-9.1%)的病例需要进行有意膀胱切开术,而 7.2%(95%CI,6.0%-8.5%)的病例发生无意膀胱切开术。行子宫切除术的患者中有 19.4%(95%CI,16.3%-22.7%)发生泌尿系统并发症,行保守治疗的患者中有 12.2%(95%CI,7.5%-17.8%)发生泌尿系统并发症。在亚组分析中,胎盘植入/胎盘粘连患者中泌尿系统并发症发生率为 9.4%(95%CI,5.4%-14.4%),胎盘穿透性患者中发生率为 38.5%(95%CI,21.6%-57.0%),主要为膀胱切开术(5.5%(95%CI,0.6%-15.1%)和 22.0%(95%CI,5.4%-45.5%))。计划性手术患者中有 15.4%(95%CI,8.1%-24.6%)发生泌尿系统并发症,紧急手术患者中有 24.6%(95%CI,13.0%-38.5%)发生泌尿系统并发症。对每年报告≥12 例病例的研究进行亚组分析,泌尿系统并发症发生率与主要分析结果相似。

结论

行 PAS 手术的女性发生泌尿系统并发症的风险较高,主要为膀胱切开术。在描述为胎盘穿透性的女性和行紧急手术干预的女性中,这些并发症的发生率特别高。纳入研究之间的高度异质性突显了需要制定 PAS 的标准化诊断方案,以识别与分娩时泌尿系统发病率增加相关的产前影像学征象。© 2023 年国际妇产科超声学会。

相似文献

1
Urological complications in women undergoing Cesarean section for placenta accreta spectrum disorders: systematic review and meta-analysis.女性行剖宫产术治疗胎盘植入谱系疾病的泌尿系统并发症:系统评价和荟萃分析。
Ultrasound Obstet Gynecol. 2023 Nov;62(5):633-643. doi: 10.1002/uog.26299.
2
Risk factors, prenatal diagnosis, and outcome of posterior placenta accreta spectrum disorders in patients with placenta previa or low-lying placenta: A multicenter study.前置胎盘或低置胎盘患者发生胎盘植入谱系疾病的危险因素、产前诊断及结局:一项多中心研究
Acta Obstet Gynecol Scand. 2025 Jul;104(7):1328-1338. doi: 10.1111/aogs.15132. Epub 2025 May 19.
3
Prenatal ultrasound diagnosis and outcome of placenta previa accreta after cesarean delivery: a systematic review and meta-analysis.剖宫产术后胎盘植入的产前超声诊断及结局:一项系统评价与荟萃分析
Am J Obstet Gynecol. 2017 Jul;217(1):27-36. doi: 10.1016/j.ajog.2017.02.050. Epub 2017 Mar 6.
4
Overactive Bladder Syndrome Following Cesar ean Hysterectomy for Placenta Accreta Spectrum, A Cohort Study.胎盘植入谱系疾病剖宫产子宫切除术后膀胱过度活动症综合征:一项队列研究
Int Urogynecol J. 2025 Apr 10. doi: 10.1007/s00192-025-06116-y.
5
Comparison of maternal outcomes and clinical characteristics of prenatally vs nonprenatally diagnosed placenta accreta spectrum: a systematic review and meta-analysis.比较产前与非产前诊断的胎盘植入谱系疾病的产妇结局和临床特征:系统评价和荟萃分析。
Am J Obstet Gynecol MFM. 2023 Dec;5(12):101197. doi: 10.1016/j.ajogmf.2023.101197. Epub 2023 Oct 20.
6
Placenta accreta spectrum disorder: A systematic review and meta-analysis on conservative surgery.胎盘植入谱系疾病:关于保守性手术的系统评价和荟萃分析
Int J Gynaecol Obstet. 2025 Jun 24. doi: 10.1002/ijgo.70322.
7
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
8
Outcome of Cesarean scar pregnancy managed expectantly: systematic review and meta-analysis.期待治疗剖宫产瘢痕妊娠的结局:系统评价和荟萃分析。
Ultrasound Obstet Gynecol. 2018 Feb;51(2):169-175. doi: 10.1002/uog.17568.
9
Maternal and neonatal outcomes of elective induction of labor.择期引产的母婴结局
Evid Rep Technol Assess (Full Rep). 2009 Mar(176):1-257.
10
Antenatal corticosteroids prior to planned caesarean at term for improving neonatal outcomes.择期剖宫产术前应用产前皮质激素以改善新生儿结局。
Cochrane Database Syst Rev. 2021 Dec 22;12(12):CD006614. doi: 10.1002/14651858.CD006614.pub4.

引用本文的文献

1
Combined First-Trimester PAPP-A and Free β-hCG Levels for the Early Diagnosis of Placenta Accreta Spectrum and Placenta Previa: A Case-Control Study.孕早期联合检测妊娠相关血浆蛋白-A和游离β-人绒毛膜促性腺激素水平用于前置胎盘和胎盘植入谱系疾病的早期诊断:一项病例对照研究
Int J Mol Sci. 2025 Jun 27;26(13):6187. doi: 10.3390/ijms26136187.
2
Placenta accreta spectrum.胎盘植入谱系疾病
Nat Rev Dis Primers. 2025 Jun 5;11(1):40. doi: 10.1038/s41572-025-00624-3.
3
Overactive Bladder Syndrome Following Cesar ean Hysterectomy for Placenta Accreta Spectrum, A Cohort Study.
胎盘植入谱系疾病剖宫产子宫切除术后膀胱过度活动症综合征:一项队列研究
Int Urogynecol J. 2025 Apr 10. doi: 10.1007/s00192-025-06116-y.
4
Intended Conservative Management Versus Caesarean Hysterectomy for Known or Suspected Placenta Accreta Spectrum: A Cost-Effectiveness Analysis.已知或疑似胎盘植入谱系疾病的预期保守治疗与剖宫产子宫切除术:成本效益分析
BJOG. 2025 Jul;132(8):1096-1103. doi: 10.1111/1471-0528.18025. Epub 2024 Dec 5.
5
Diffusion lacunae: a novel MR imaging finding on diffusion-weighted imaging for diagnosing placenta accreta spectrum.扩散腔隙:一种用于诊断胎盘植入谱系的扩散加权成像上新的磁共振成像表现。
Jpn J Radiol. 2025 Feb;43(2):255-265. doi: 10.1007/s11604-024-01657-6. Epub 2024 Sep 11.
6
Addressing Diagnosis, Management, and Complication Challenges in Placenta Accreta Spectrum Disorder: A Descriptive Study.应对胎盘植入谱系障碍的诊断、管理及并发症挑战:一项描述性研究
J Clin Med. 2024 May 28;13(11):3155. doi: 10.3390/jcm13113155.
7
Vesicovaginal Fistulas: Prevalence, Impact, and Management Challenges.膀胱阴道瘘:患病率、影响及管理挑战。
Medicina (Kaunas). 2023 Nov 3;59(11):1947. doi: 10.3390/medicina59111947.